Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
October 23, 2023
In times of mounting debt, the quest for universal health coverage (UHC) faces critical challenges. Rising debt has far-reaching effects, including reduced access to financing, political instability, and decreased spending on international aid. The burden of debt, coupled with high inflation, is thr...
Blog Post
October 16, 2023
The real test after the meetings will be how to identify sources of concessional financing for middle-income countries while still delivering on IDA. Donors have leaned heavily on capital adequacy reforms and private sector mobilization as sources of finance, but there is no escaping the fact that t...
Blog Post
September 22, 2023
We’ve updated our 2022 working paper with Laura Moscoviz on long run trends in education quality with several new surveys from around the world. Notably, a new survey round for India (NFHS-5) casts doubt on earlier data (NFHS-3). Dropping the suspect data, India’s current learning levels are unchang...
Blog Post
September 11, 2023
It is standard fare for the G20 to issue lofty statements without any real muscle behind them, but the discordance in this year’s declaration is especially grating because explicitly and implicitly, the G20 have heaped exceptionally large burdens on the MDBs all in the context of what the leaders ac...
Blog Post
September 08, 2023
As the G20 India Summit approaches, India is taking a central seat on the global stage. While much attention will focus on India’s positive economic accomplishments, some of the spotlight will inevitably be on the country’s slow advances on women’s economic empowerment. On paper, India’s family-frie...
Blog Post
September 05, 2023
Today the Africa Centers for Disease Control’s (ACDC) Health Economics Programme (HEP) has published a new policy brief on the cost-effectiveness of two COVID-19 oral antivirals (COAVs), a nirmatrelvir/ritonavir combination, developed by Pfizer and sold under the name Paxlovid, and Molnupiravir, dev...
Blog Post
September 05, 2023
We know from data across countries that far too many children around the world experience violence at school. For example, evidence from 20 African countries shows high rates of both physical and sexual violence. But qualitative studies with smaller samples or more targeted quantitative studies can ...
POLICY PAPERS
September 05, 2023
The G20 is well placed to provide the leadership needed to ensure that research is a global public good by elevating the discourse on research publishing reform and acknowledging that this is not merely a niche concern for researchers but an important global challenge that underpins human progress.